LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...
U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication DemandAustin, May 06, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ibuprofen API Market size ...
Ensuring compatibility between an active pharmaceutical ingredient (API) and its excipients is a critical facet of drug development, influencing stability, efficacy and safety of the final dosage form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results